Expertise in
15
conditions

Eric Oksenhendler

Paris, FR 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
15
conditions
Paris, FR 

Overview

Eric Oksenhendler practices practicing medicine in Paris, France.

Mr. Oksenhendler is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Castleman Disease, Multicentric Castleman Disease (MCD), Lymphoid Hyperplasia, Unicentric Castleman Disease (UCD), and Splenectomy.

He is actively involved in clinical research, co-authoring 137 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Paris, France
Other Locations
Port-saint-louis-du-rhone, France
Eu, France
Clichy-sous-bois, France
Université Paris Est Créteil, Creteil, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

ACCELERATE (Advancing Castleman Care With an Electronic Longitudinal Registry, E-Repository, And Treatment/Effectiveness Research): An International Registry for Patients With Castleman Disease
ACCELERATE (Advancing Castleman Care With an Electronic Longitudinal Registry, E-Repository, And Treatment/Effectiveness Research): An International Registry for Patients With Castleman Disease
Enrollment Status: Recruiting
Publish Date: March 03, 2026
A Pilot Trial of AVD and Brentuximab Vedotin (SGN-35) in the Treatment of Stage II-IV HIV-Associated Hodgkin Lymphoma
A Pilot Trial of AVD and Brentuximab Vedotin (SGN-35) in the Treatment of Stage II-IV HIV-Associated Hodgkin Lymphoma
Enrollment Status: Completed
Publish Date: August 15, 2025
Intervention Type: Drug, Other
Study Drugs: Brentuximab, Dacarbazine, Doxorubicin, Vinblastine
Study Phase: Phase 1/Phase 2
View 1 Less Clinical Trial

137 Total Publications

Development and Validation of the Idiopathic Multicentric Castleman Disease Symptom Burden Scale (ISBUS): Protocol for an International Multistage Mixed Methods Study.
Development and Validation of the Idiopathic Multicentric Castleman Disease Symptom Burden Scale (ISBUS): Protocol for an International Multistage Mixed Methods Study.
Journal: JMIR research protocols
Published: March 24, 2026

Frequently Asked Questions about Eric Oksenhendler

Is Eric Oksenhendler a top-rated expert for Castleman Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Eric Oksenhendler is classified as an Elite expert for Castleman Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Eric Oksenhendler participate in research or clinical trials?

Yes. Eric Oksenhendler has published 137 articles and abstracts on conditions like Castleman Disease. You can view a list of Eric Oksenhendler's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Oksenhendler's expertise for a condition
ConditionClose
View All 10 Advanced Conditions
View All 36 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile